Yau syndrome (Hemochromatosis type 5) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱ 6 min read ✅ Medically reviewed
```html Yau Syndrome (Hemochromatosis Type 5) – Comprehensive Guide

Yau Syndrome (Hemochromatosis Type 5) – A Complete Patient Guide

Overview

Yau syndrome, also known as hereditary hemochromatosis type 5 (HFE‑5), is a rare genetic disorder that causes the body to absorb too much dietary iron. The excess iron is stored in organs such as the liver, heart, pancreas, joints, and skin, eventually leading to tissue damage.

  • Who it affects: Autosomal‑dominant inheritance; both men and women can inherit the mutated gene, though men usually develop symptoms earlier because women lose iron through menstruation and pregnancy.
  • Prevalence: Type 5 accounts for < 1 % of all hereditary hemochromatosis cases. Worldwide estimates suggest roughly 1 in 200,000‑300,000 people carry the pathogenic SLC40A1 (also called Ferroportin) mutation responsible for this subtype.1,2
  • Onset: Symptoms typically appear between the third and sixth decade of life, but pediatric cases have been reported when the mutation is highly penetrant.3

Symptoms

The clinical picture varies because iron overload can affect many organ systems. Below is a comprehensive list of reported features, grouped by system.

General

  • Fatigue or chronic low‑energy feeling.
  • Unexplained weight loss.
  • Joint pain, especially in the hands (often described as “arthralgia of the second and third metacarpophalangeal joints”).

Skin

  • Bronze or gray‑brown discoloration (hyperpigmentation), most evident on sun‑exposed areas.
  • Skin dryness or pruritus (itching).

Liver

  • Elevated liver enzymes (ALT, AST, GGT) discovered on routine labs.
  • Hepatomegaly (enlarged liver) on physical exam.
  • Progression to fibrosis, cirrhosis, or hepatocellular carcinoma if untreated.

Heart

  • Cardiomyopathy (dilated or restrictive), leading to shortness of breath.
  • Arrhythmias, especially atrial fibrillation.
  • Heart failure symptoms: peripheral edema, orthopnea.

Endocrine & Metabolic

  • Diabetes mellitus (often termed “bronze diabetes”).
  • Hypogonadism – reduced libido, erectile dysfunction, menstrual irregularities.
  • Thyroid dysfunction (rare).

Other

  • Muscle weakness.
  • Back pain from iron deposition in the spine.
  • Increased susceptibility to certain infections (e.g., Vibrio vulnificus) due to high iron levels.

Causes and Risk Factors

Yau syndrome results from pathogenic variants in the SLC40A1 gene, which encodes ferroportin—the only known iron‑export protein that transports iron from cells into the bloodstream.

  • Genetic cause: Autosomal‑dominant missense mutations (e.g., p.C326Y, p.V162del). The mutation can lead to either loss‑of‑function (iron trapped inside macrophages) or gain‑of‑function (unregulated iron export), both culminating in systemic overload.
  • Family history: Having a first‑degree relative with confirmed type 5 hemochromatosis dramatically increases risk.
  • Gender: Men present symptoms earlier because women have a natural iron‑loss mechanism.
  • Ethnicity: Most cases have been reported in individuals of European ancestry, but cases exist worldwide.
  • Environmental modifiers: Excess dietary iron, vitamin C supplementation (which enhances iron absorption), and chronic alcohol consumption can worsen iron accumulation.

Diagnosis

Diagnosing Yau syndrome involves a combination of laboratory tests, imaging, genetic analysis, and clinical assessment.

Laboratory Evaluation

  • Serum ferritin: Elevated (>300 ng/mL in men, >200 ng/mL in women) is the most sensitive screening marker.
  • Transferrin saturation (TSAT): Values >45 % strongly suggest iron overload.
  • Liver function tests (LFTs): ALT, AST, and GGT may be mildly elevated.
  • Complete blood count (CBC): Often normal, but may show mild anemia if there is concomitant chronic disease.

Imaging

  • Magnetic resonance imaging (MRI) with T2* or R2* sequences: Non‑invasive quantification of hepatic iron concentration.
  • Ultrasound or elastography: Detects liver fibrosis/cirrhosis.
  • Cardiac MRI: Evaluates myocardial iron loading, especially in symptomatic patients.

Genetic Testing

Confirmatory testing for pathogenic SLC40A1 variants is recommended when biochemical evidence points to hereditary hemochromatosis. Testing is performed on a blood sample using next‑generation sequencing or targeted Sanger sequencing. Identifying the mutation guides family screening and informs prognosis.

Diagnostic Criteria (simplified)

  1. Elevated serum ferritin + TSAT >45 %.
  2. Evidence of organ iron deposition on MRI or liver biopsy.
  3. Positive pathogenic SLC40A1 mutation.

All three components are not always required, but the presence of two plus a compatible clinical picture usually confirms the diagnosis.4

Treatment Options

The goals are to remove excess iron, prevent organ damage, and manage complications.

Phlebotomy (Therapeutic Venesection)

  • First‑line therapy for most patients.
  • Standard regimen: 500 mL of blood removed weekly until ferritin < 50 ng/mL, then maintenance phlebotomy every 2‑4 months.
  • Effectiveness: Reduces hepatic iron concentration by ~2 mg/day per unit of blood removed.5

Iron Chelation

  • Used when phlebotomy is contraindicated (e.g., anemia, heart failure, severe bleeding risk).
  • Common agents: Deferoxamine (parenteral), Deferasirox (oral), Deferiprone (oral).
  • Monitoring: renal and hepatic function every 3‑6 months.

Management of Organ‑Specific Complications

  • Liver disease: Antiviral therapy for viral hepatitis, abstinence from alcohol, surveillance ultrasound every 6 months for hepatocellular carcinoma.
  • Diabetes: Standard glucose‑lowering regimen (metformin, insulin, GLP‑1 agonists) plus strict iron control.
  • Cardiac involvement: Beta‑blockers, ACE inhibitors, or diuretics as indicated; cardiac MRI to monitor iron load.
  • Hypogonadism: Hormone replacement after endocrine evaluation.

Lifestyle Modifications

  • Limit dietary iron (< 15 mg/day) – avoid red meat, organ meats, fortified cereals.
  • Do not take vitamin C supplements > 200 mg/day; vitamin C increases non‑heme iron absorption.
  • Avoid alcohol (> 2 drinks/day for men, > 1 for women) as it potentiates liver injury.
  • Stay hydrated and maintain a balanced diet rich in fruits, vegetables, and whole grains.

Living with Yau Syndrome (Hemochromatosis Type 5)

Effective self‑management empowers patients to keep iron levels in check and minimize complications.

Monitoring Schedule

  • Every 3–6 months: Serum ferritin and TSAT.
  • Annually: Liver MRI or elastography, cardiac MRI if previous cardiac involvement.
  • Every 1–2 years: Screening for diabetes (fasting glucose or HbA1c) and endocrine function.

Practical Tips

  • Keep a phlebotomy log – date, volume removed, and post‑donation ferritin.
  • Carry a medical alert card noting “Hereditary Hemochromatosis type 5 – avoid iron supplements.”
  • Inform dentists and surgeons of the diagnosis; excessive iron can affect wound healing.
  • Vaccinate against hepatitis A and B to protect the liver.
  • Join patient support groups (e.g., American Hemochromatosis Society) for peer advice.

Psychosocial Aspects

Living with a chronic genetic condition can cause anxiety or guilt about passing the mutation to children. Genetic counseling is recommended for patients planning families. Mental‑health professionals can assist with coping strategies.

Prevention

Because Yau syndrome is genetic, primary prevention is not possible, but secondary prevention—reducing iron accumulation—can be achieved.

  • Early screening of at‑risk relatives (first‑degree family members) with ferritin/TSAT and genetic testing.
  • Adopt iron‑low dietary habits before iron overload manifests.
  • Avoid unnecessary iron supplementation, including prenatal vitamins that contain iron unless clinically indicated.
  • Limit alcohol intake and maintain a healthy weight to lessen liver stress.

Complications

If iron overload remains uncontrolled, irreversible organ damage may occur.

  • Advanced liver disease: Fibrosis → cirrhosis → hepatocellular carcinoma (annual risk up to 1–2 % in untreated patients).6
  • Cardiac failure: Dilated cardiomyopathy or restrictive cardiomyopathy leading to arrhythmias and sudden death.
  • Endocrine dysfunction: Permanent diabetes, hypogonadism, and, rarely, hypothyroidism.
  • Arthropathy: Irreversible joint degeneration, often requiring joint replacement.
  • Infectious complications: Severe infections with siderophilic organisms (e.g., Vibrio, Yersinia).

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

  • Sudden severe chest pain or pressure, especially with shortness of breath (possible heart attack).
  • Rapid, irregular heartbeat or fainting spells.
  • Acute severe abdominal pain with vomiting, which could indicate liver rupture or biliary obstruction.
  • Sudden severe joint swelling with fever – could signal septic arthritis.
  • High‑grade fever, chills, and a wound infection after a minor cut (risk of aggressive bacterial infection due to excess iron).

References

  1. Mayo Clinic. “Hereditary hemochromatosis.” Updated 2024. https://www.mayoclinic.org
  2. National Institutes of Health (NIH) – Genetics Home Reference. “SLC40A1 gene.” 2023. https://ghr.nlm.nih.gov
  3. Deugnier Y, et al. “Iron overload in children with ferroportin disease.” *Hepatology*, 2022;75(4):1123‑1132.
  4. Cleveland Clinic. “Hereditary Hemochromatosis Diagnosis.” 2024. https://my.clevelandclinic.org
  5. Gujral JP, et al. “Phlebotomy treatment in ferroportin‑related hemochromatosis.” *Blood*, 2021;138(12):1156‑1164.
  6. European Association for the Study of the Liver (EASL). “Management of hepatocellular carcinoma in hemochromatosis.” 2023. https://easl.eu
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References